HomeE4NA • FRA
add
Arovella Therapeutics Ltd
Previous close
€0.041
Day range
€0.042 - €0.042
Year range
€0.035 - €0.13
Market cap
99.21M AUD
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 415.00 | -90.24% |
Operating expense | 3.10M | 27.39% |
Net income | -3.02M | -25.98% |
Net profit margin | -728.62K | -1,190.20% |
Earnings per share | — | — |
EBITDA | -3.07M | -26.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.88M | 64.20% |
Total assets | 21.60M | 62.60% |
Total liabilities | 1.52M | -25.89% |
Total equity | 20.08M | — |
Shares outstanding | 1.19B | — |
Price to book | 2.02 | — |
Return on assets | -35.83% | — |
Return on capital | -38.55% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.02M | -25.98% |
Cash from operations | -2.56M | -19.69% |
Cash from investing | -36.50K | 22.90% |
Cash from financing | 7.16M | 16.20% |
Net change in cash | 4.56M | 14.78% |
Free cash flow | -1.77M | -35.94% |
About
Founded
1999
Website
Employees
14
